Immunomedics 8-K 2010
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 11, 2010
(Exact Name of Registrant as Specified in Charter)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed on May 3, 2010, Dr. Edward T. Wolynic had informed Immunomedics, Inc. (the “Company”) of his intention not to stand for re-election at the Company’s next Annual Meeting of Stockholders, scheduled to be held in December 2010. However, due to an increase in demand for his consulting and advisory services, on June 11, 2010, Dr. Wolynic informed the Company that his resignation will now be effective as of June 14, 2010. Dr. Wolynic has also informed the Company that his resignation is not due to any disagreement between Dr. Wolynic and the Company on any matter relating to the Company’s operations, policies or practices.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 17, 2010